Chemotherapy

The FDA approved alectinib as an adjuvant treatment for patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer following tumor resection and detection by an FDA-approved test.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

Two blood biomarkers — pre-lymphodepletion C-reactive protein and ferritin — may help predict which patients with lymphoma are at risk for poor outcomes after chimeric antigen receptor T-cell therapy.

Healio spoke with Wendy Chen, MD, MPH about recent advancements in metastatic triple-negative breast cancer.

Healio spoke with Wendy Chen, MD, MPH about recent advancements in metastatic triple-negative breast cancer.

Healio spoke with Wendy Chen, MD, MPH about recent advancements in metastatic triple-negative breast cancer.

Healio spoke with Wendy Chen, MD, MPH about recent advancements in metastatic triple-negative breast cancer.

Healio spoke with Wendy Chen, MD, MPH about recent advancements in metastatic triple-negative breast cancer.

Sentinel lymph node biopsy may be omitted in certain patients with early-stage breast cancer, according to findings presented at American Society of Breast Surgeons Annual Meeting.

ATLANTA — Enalapril plus standard care was not superior to standard care alone for preventing cardiotoxicity in patients receiving treatment for breast cancer or lymphoma, according to new data from the PROACT trial.